Informing Low-acuity Emergency Department Patients of Non-emergent Resources

Not Applicable

Completed

• Conditions: Emergency Service, Hospital

• Registration Number: NCT06350266
• Lead Sponsor: Geisinger Clinic

Brief Summary

The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED)/encourage patients with high acuity visits to follow up with an appropriate Geisinger provider. In this campaign, patients will be assigned to receive or not receive outreach following ED discharge that is aligned with the goal. Outreach will occur via a text message, as well as information added to the patient's after visit summary, and will includecalls to action to see their Geisinger CMSL PCP either in person or virtually. The study will assess whether ED use differs across patients in different outreach conditions. It will also examine whether patients follow through on the message-specific calls to action in the messages differently across conditions.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-04-01
• Study First Submitted QC: 2024-04-01
• Study First Posted: 2024-04-05
• Study Start: 2024-04-25
• Primary Completion: 2024-12-27
• Study Completion: 2024-12-27
• Status Verified: 2025-01
• Last Update Submitted: 2025-01-08
• Last Update Posted: 2025-03-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 6242

Inclusion Criteria

• >= 18 years of age
• Geisinger ED visit rated as low acuity (L4 or L5)
• Discharged from Geisinger ED in past 24 hours

Exclusion Criteria

• Cannot be contacted via the communication modality being used in the study (i.e., SMS), due to insufficient/missing contact information in the EHR or because the patient opted out
• Admitted to hospital
• Already included in intervention in past 365 days

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Return to Geisinger ED	within 120 days following day of discharge	ED visit (yes/no)

Trial Locations

Locations (1)

Geisinger Health System; 🇺🇸 Danville, Pennsylvania, United States